Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
March 15 2022 - 4:06PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
6-K
REPORT
OF FOREIGN PRIVATE ISSUER
PURSUANT
TO RULE 13a-16 OR 15d-16
UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For
the month of March 2022
Commission
File Number: 333-256665
MOXIAN
(BVI) INC
Unit
911, Tower 2, Silvercord, 30 Canton Road
Hong
Kong SAR, China
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Form
20-F ☒ Form 40-F ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
Explanatory Note:
Effective March 11, 2022, Mr. Hao Qinghu has resigned
as a member and Chairman of the board of directors (the “Board”) of the Company. Mr. Hao’s resignation
was for personal reasons and was not the result of any disagreement with the management, the Board or the Company.
Effective March 11,
2022, the Board has appointed Ms. Wang Panpan as a director of the Company. There is no relationships or related transactions
between Ms. Wang and the Company that would be required to be reported under Section 404(a) of Regulation S-K.
Ms. Wang previously served as a director of
the Company from August 9, 2021 to November 22, 2021. Age 31, Ms. Wang has been a Deputy Director at the People’s
Health Network Co. Ltd., a health news portal based in Beijing since December 2018 where she is responsible for government
relations and market expansion. From August 2013 to December 2018, she had served as a Department Manager with the People’s
Daily Online, the largest newspaper group in China. Ms. Wang obtained a Bachelor’s degree in Media Economy from the Communication
University of China in 2013 and a Master’s degree in Public Administration from Beijing Normal University in 2018.
The
Board has determined that Ms. Wang is qualified to serve as a director of the Company.
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its
behalf by the undersigned hereunto duly authorized.
|
MOXIAN (BVI) INC |
|
|
|
Date: March 15, 2022 |
By: |
/s/ Deng
Conglin |
|
Name: |
Deng Conglin |
|
Title : |
Chief Executive Officer |
Moxian (NASDAQ:MOXC)
Historical Stock Chart
From Oct 2024 to Nov 2024
Moxian (NASDAQ:MOXC)
Historical Stock Chart
From Nov 2023 to Nov 2024